Risk of caffeine toxicity associated with the use of 'legal highs' (novel psychoactive substances)

European Journal of Clinical Pharmacology

Volumn 68, Issue 4, 2012, Pages 435-439

  Davies, Susannah ^a   Lee, Terry ^a   Ramsey, John ^b   Dargan, Paul I ^c,d   Wood, David M ^c,d  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Caffeine; Legal highs; Novel psychoactive substances; Taurine; Toxicity

Indexed keywords

BLOWOUT; CAFFEINE; IVORY WAVE; LEGAL HIGH; PSYCHOTROPIC AGENT; RECREATIONAL DRUG; SN BERRY; SNOW BLOW; SYNTHACAINE; TAURINE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ARTICLE; DRUG MARKETING; DRUG USE; HUMAN; HYPOKALEMIA; INFRARED SPECTROSCOPY; INTERNET; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; POLICE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; UNITED KINGDOM;

CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; PSYCHOTROPIC DRUGS; RISK; SPECTROPHOTOMETRY, INFRARED; STREET DRUGS; TANDEM MASS SPECTROMETRY; TAURINE;

EID: 84860302741     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1144-y     Document Type: Article

References (28)

1. EMCDDA (2010) EMCDDA-Europol 2010 annual report on the implementation of Council Decision 2005/387/JHA. http://www.emcdda.europa.eu/attachements.cfm/att- 132857-EN-EMCDDAEuropol% 20Annual%20Report%202010A.pdf. Accessed 11 Aug 2011
2. Hillebrand J, Olszewski D, Sedefov R (2010) Legal highs on the Internet. Subst Use Misuse 45:330-340
3. Dargan PI, Sedefov R, Gallegos A, Wood DM (2011) The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test Anal 3:454-463
4. Lidder S, Dargan PI, Sexton M, Button J, Ramsey J, Holt DW, Wood DM (2008) Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol (D2PM)). J Med Toxicol 4:167-169
5. Wood DM, Dargan PI, Button J, Holt DW, Ovaska H, Ramsey J, Jones AL (2007) Collapse, reported seizure-and an unexpected pill. Lancet 369:1490 (Pubitemid 46635785)
6. Wood DM, Ramsey J, Dargan PI (2008) Detecting novel and emerging recreational drugs on the 'club scene'. Irish Psychiatrist 9:223-228
7. Brandt SD, Sumnall HR,Measham F, Cole J (2010) Second generation mephedrone. The confusing case of NRG-1. BMJ 341:c3564
8. Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J (2011) Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones. Drug Test Anal. doi:10.1002/ dta.204
9. Ramsey J, Dargan PI, Smyllie M, Davies S, Button J, Holt DW, Wood DM (2010) Buying 'legal' recreational drugs does not mean that you are not breaking the law. QJM 103:777-783
10. Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, Holt DW, Dargan PI (2010) Purchasing 'legal highs' on the Internet-is there consistency in what you getč QJM 103:489-493
11. Berger AJ, Alford K (2009) Cardiac arrest in a young man following excess consumption of caffeinated "energy drinks". Med J Aust 190:41-43
12. Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE (2011) Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 127:511-528
13. Trabulo D, Marques S, Pedroso E (2011) Caffeinated energy drink intoxication. BMJ Case Rep. doi:10.1136/bcr.09.2010.3322
14. Clauson KA, Shields KM, McQueen CE, Persad N (2008) Safety issues associated with commercially available energy drinks. J Am Pharm Assoc 48(3):e55-e63
15. Reissig CJ, Strain EC, Griffiths RR (2009) Caffeinated energy drinks-a growing problem. Drug Alcohol Depend 99:1-10
16. US Dept of Health and Human Services (2010) FDAWarning Letters issued to four makers of caffeinated alcoholic beverages. http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm234109. htm. Accessed 11 Aug 2011
17. Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M (2011) Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal 3:89-96
18. Passmore AP, Kondowe GB, Johnston GD (1986) Caffeine and hypokalemia. Ann Intern Med 105:468 (Pubitemid 16014329)
19. Gennari FJ (1998) Hypokalemia. N Engl J Med 339:451-458 (Pubitemid 28377688)
20. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101-163
21. Kendler BS (1989) Taurine: an overview of its role in preventive medicine. Prev Med 18:79-100 (Pubitemid 19128814)
22. European Commission (1999) Opinion on caffeine, taurine and Dglucurono- γ-lactone as constituents of so-called "energy" drinks. http://ec.europa.eu/food/fs/sc/scf/out22-en.html. Accessed 11 Aug 2011
23. Food Standards Agency (1998) Joint Food Safety Standards Group food surveillance information sheet number 144. Survey of caffeine and other methylxanthines in energy drinks and other caffeine-containing products (updated). http://archive.food.gov.uk/ maff/archive/food/infsheet/1998/no144/ 144caff.htm. Accessed 11 Aug 2011
24. Shum S, Seale C, Hathaway D, Chucovich V, Beard D (1997) Acute caffeine ingestion fatalities: management issues. Vet Hum Toxicol 39:228-230 (Pubitemid 27306670)
25. Leson CL, McGuigan MA, Bryson SM (1988) Caffeine over-dose in an adolescent male. J Toxicol Clin Toxicol 26:407-415
26. Fisher AA, Davis MW (2002) Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction. Ann Pharmacother 36:67-71 (Pubitemid 34052947)
27. Boyer EW, Shannon M (2005) The serotonin syndrome. N Engl J Med 352:1112-1120
28. Waring WS, Laing WJ, Good AM, Malkowska AM (2009) Acute caffeine ingestion: clinical features in patients attending the emergency department and Scottish poison centre enquiries between 2000 and 2008. Scott Med J 54:3-6